Yield Theory

Jefferson Shreve · CTAS

Jefferson Shreve's CTAS trades

Every Cintas Corporation transaction Jefferson Shreve reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
3
Buys / sells
1 / 2
Disclosed range
$115K – $250K
Last filed
2025-06-22

CTAS transactions reported by Jefferson Shreve

3 of 3 rows
TypeOwner
Cintas Corporation - Common Stock
CTAS
SaleSelf$50,001 - $100,0002025-06-22
#20030387
Cintas Corporation - Common Stock
CTAS
SaleSelf$15,001 - $50,0002025-06-22
#20030387
Cintas Corporation - Common Stock
CTAS
PurchaseSelf$50,001 - $100,0002025-05-08
#20030231

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Jefferson Shreve and CTAS — questions

Did Jefferson Shreve buy or sell CTAS?

House Clerk filings for 2025 and 2026 show 1 purchase and 2 sales of Cintas Corporation (CTAS) reported by Jefferson Shreve, between 2025-04-07 and 2025-05-12. Reported owner: Self.

How much CTAS did Jefferson Shreve trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $115K – $250K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last CTAS filing by Jefferson Shreve?

The most recent periodic transaction report containing a CTAS row was filed on 2025-06-22. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Cintas Corporation. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Jefferson Shreve CTAS disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included